logo
Loading...
New liposidomycin congeners produced by *Streptomyces* sp. TMPU-20A065, anti-*Mycobacterium avium* complex agents with therapeutic efficacy in a silkworm infection model
Medicine and HealthThe Journal of Antibiotics

New liposidomycin congeners produced by *Streptomyces* sp. TMPU-20A065, anti-*Mycobacterium avium* complex agents with therapeutic efficacy in a silkworm infection model

A. Yagi, M. Fujiwara, et al.

Discover the potential of new liposidomycin congeners as anti-*Mycobacterium avium* complex agents! Researchers Akiho Yagi, Mayu Fujiwara, Mayu Sato, Yuzu Abe, and Ryuji Uchida have isolated three novel compounds, revealing exciting in vitro activities and promising therapeutic effects in a silkworm infection model.... show more
GeneralSummaryMetrics
Abstract
Three new liposidomycin congeners (1, 2, and 4), together with 14 known liposidomycins (3 and 5–17), were isolated from the culture broth of Streptomyces sp. TMPU-20A065 as anti-Mycobacterium avium complex agents. The structures of liposidomycins were elucidated by spectroscopic analyses, including NMR and MS. Compounds 1, 2, and 4 belong to type-I liposidomycin-containing sulfate groups and methylglutaric acid, each with a different acyl side chain in the structure. Compounds 1–17 exhibited in vitro anti-M. avium and M. intracellulare activities with MIC values ranging between 2.0 and 64 µg ml⁻¹. Furthermore, 1–17 exerted potent therapeutic effects in an in vivo-mimic silkworm infection model with ED₅₀ values ranging between 0.12 and 3.7 µg larva⁻¹ g⁻¹.
Publisher
The Journal of Antibiotics
Published On
May 08, 2024
Authors
Akiho Yagi, Mayu Fujiwara, Mayu Sato, Yuzu Abe, Ryuji Uchida
DOI
https://doi.org/10.1038/s41429-024-00724-4
Tags
liposidomycinanti-*Mycobacterium avium*Streptomycesin vitro activitytherapeutic effectssilkworm modelNMR and MS
Related Publications

Explore these studies to deepen your understanding

Adjacent work that informs or extends this paper's methodology and findings.

Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer
Medicine and Health

Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer

C. Zheng, D. Zhou, et al.

Dietary prebiotics promote intestinal *Prevotella* in association with a low-responding phenotype in a murine oxazolone-induced model of atopic dermatitis
Veterinary Science

Dietary prebiotics promote intestinal *Prevotella* in association with a low-responding phenotype in a murine oxazolone-induced model of atopic dermatitis

A. Laigaard, L. Krych, et al.

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
Medicine and Health

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial

S. Mukherjee, C. N. Hurt, et al.

A critical role of brain network architecture in a continuum model of autism spectrum disorders spanning from healthy individuals with genetic liability to individuals with ASD
Medicine and Health

A critical role of brain network architecture in a continuum model of autism spectrum disorders spanning from healthy individuals with genetic liability to individuals with ASD

B. Khundrakpam, N. Bhutani, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny